ArticleEFSA journal. European Food Safety Authority2021
ASF Exit Strategy: Providing cumulative evidence of the absence of African swine fever virus circulation in wild boar populations using standard surveillance measures.
Article in EFSA journal. European Food Safety Authority, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 37 citations in OpenAlex.
- Integrated Hunting Strategies for African Swine Fever Control in Wild Boar: A Comparative Review of Experiences in European Continent.Veterinary sciences · 2026Review
- Passengers as Pathways: Behavioral Evidence on Travelers' Knowledge of African Swine Fever Introduction Through Pork Products.Veterinary sciences · 2026Article
- Early African Swine Fever Dynamics in Wild Boar After Reemergence in Catalonia, Spain: Surveillance-Based Estimates of Initial Spread.Transboundary and emerging diseases · 2026Article
- Spatio-Temporal Dynamics of African Swine Fever in Free-Ranging Wild Boar (Veterinary sciences · 2025Article
- Risk Factors for African Swine Fever in Wild Boar in Russia: Application of Regression for Classification Algorithms.Animals : an open access journal from MDPI · 2025Article
- Maternal immunity and African swine fever virus: understanding the limits of passive protection.Frontiers in immunology · 2025Article
- African swine fever in wild boar: investigating model assumptions and structure.Royal Society open science · 2024Article
- Article
- Geospatial analysis for strategic wildlife disease surveillance: African swine fever in South Korea (2019-2021).PloS one · 2024Article
- The Effect of Partial and Temporary Vaccination on African Swine Fever Eradication Rates.Transboundary and emerging diseases · 2024Article
- Spatiotemporal Patterns of African Swine Fever in Wild Boar in the Russian Federation (2007-2022): Using Clustering Tools for Revealing High-Risk Areas.Animals : an open access journal from MDPI · 2023Article
- Estimating the Directional Spread of Epidemics in Their Early Stages Using a Simple Regression Approach: A Study on African Swine Fever in Northern Italy.Pathogens (Basel, Switzerland) · 2023Article
- Estimation of RViruses · 2022Article
- Estimating the risk of environmental contamination by forest users in African Swine Fever endemic areas.Acta veterinaria Scandinavica · 2022Article
- Changes in Estimating the Wild Boar Carcasses Sampling Effort: Applying the EFSA ASF Exit Strategy by Means of theViruses · 2022Article
- Eight Years of African Swine Fever in the Baltic States: Epidemiological Reflections.Pathogens (Basel, Switzerland) · 2022Article
- Combining hunting and intensive carcass removal to eradicate African swine fever from wild boar populations.Preventive veterinary medicine · 2022Article
- Epidemiological analyses of African swine fever in the European Union: (September 2020 to August 2021).EFSA journal. European Food Safety Authority · 2022Article
- Adaptive Cellular Immunity against African Swine Fever Virus Infections.Pathogens (Basel, Switzerland) · 2022Review
- African Swine Fever Outbreaks in Lithuanian Domestic Pigs in 2019.Animals : an open access journal from MDPI · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
EFSA assessed the role of seropositive wild boar in African swine fever (ASF) persistence. Surveillance data from Estonia and Latvia investigated with a generalised equation method demonstrated a significantly slower decline in seroprevalence in adult animals compared with subadults. The seroprevalence in adults, taking more than 24 months to approach zero after the last detection of ASFV circulation, would be a poor indicator to demonstrate the absence of virus circulation. A narrative literature review updated the knowledge on the mortality rate, the duration of protective immunity and maternal antibodies and transmission parameters. In addition, parameters potentially leading to prolonged virus circulation (persistence) in wild boar populations were reviewed. A stochastic explicit model was used to evaluate the dynamics of virus prevalence, seroprevalence and the number of carcasses attributed to ASF. Secondly, the impact of four scenarios on the duration of ASF virus (ASFV) persistence was evaluated with the model, namely a: (1) prolonged, lifelong infectious period, (2) reduction in the case-fatality rate and prolonged transient infectiousness; (3) change in duration of protective immunity and (4) change in the duration of protection from maternal antibodies. Only the lifelong infectious period scenario had an important prolonging effect on the persistence of ASF. Finally, the model tested the performance of different proposed surveillance strategies to provide evidence of the absence of virus circulation (Exit Strategy). A two-phase approach (Screening Phase, Confirmation Phase) was suggested for the Exit Strategy. The accuracy of the Exit Strategy increases with increasing numbers of carcasses collected and tested. The inclusion of active surveillance based on hunting has limited impact on the performance of the Exit Strategy compared with lengthening of the monitoring period. This performance improvement should be reasonably balanced against an unnecessary prolonged 'time free' with only a marginal gain in performance. Recommendations are provided for minimum monitoring periods leading to minimal failure rates of the Exit Strategy. The proposed Exit Strategy would fail with the presence of lifelong infectious wild boar. That said, it should be emphasised that the existence of such animals is speculative, based on current knowledge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.